{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:08:17Z","timestamp":1793250497054,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06199-z","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T04:45:04Z","timestamp":1737607504000},"page":"1317-1328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Post-transplant cyclophosphamide versus anti-thymocyte globulin in haploidentical stem cell transplantation: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"104","author":[{"given":"Xuelian","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"6199_CR1","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/s2352-3026(19)30256-x","volume":"7","author":"O Penack","year":"2020","unstructured":"Penack O, Marchetti M, Ruutu T et al (2020) Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and marrow transplantation. Lancet Haematol 7:e157\u2013e167. https:\/\/doi.org\/10.1016\/s2352-3026(19)30256-x","journal-title":"Lancet Haematol"},{"key":"6199_CR2","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","volume":"110","author":"SJ Lee","year":"2007","unstructured":"Lee SJ, Klein J, Haagenson M et al (2007) High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110:4576\u20134583. https:\/\/doi.org\/10.1182\/blood-2007-06-097386","journal-title":"Blood"},{"key":"6199_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ et al (2008) HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl 14:641\u2013650. https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.005","journal-title":"Biol Blood Marrow Transpl"},{"key":"6199_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1182\/blood.2021011281","volume":"138","author":"M Gooptu","year":"2021","unstructured":"Gooptu M, Romee R, St Martin A et al (2021) HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. Blood 138:273\u2013282. https:\/\/doi.org\/10.1182\/blood.2021011281","journal-title":"Blood"},{"key":"6199_CR5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/bmt.2012.79","volume":"47","author":"LP Xu","year":"2012","unstructured":"Xu LP, Liu KY, Liu DH et al (2012) A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia. Bone Marrow Transpl 47:1507\u20131512. https:\/\/doi.org\/10.1038\/bmt.2012.79","journal-title":"Bone Marrow Transpl"},{"key":"6199_CR6","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.bbmt.2012.07.003","volume":"18","author":"SO Ciurea","year":"2012","unstructured":"Ciurea SO, Mulanovich V, Saliba RM et al (2012) Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 18:1835\u20131844. https:\/\/doi.org\/10.1016\/j.bbmt.2012.07.003","journal-title":"Biol Blood Marrow Transpl"},{"key":"6199_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbmt.2009.11.011","volume":"16","author":"YL Kasamon","year":"2010","unstructured":"Kasamon YL, Luznik L, Leffell MS et al (2010) Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transpl 16:482\u2013489. https:\/\/doi.org\/10.1016\/j.bbmt.2009.11.011","journal-title":"Biol Blood Marrow Transpl"},{"key":"6199_CR8","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/hep.23533","volume":"51","author":"GB McDonald","year":"2010","unstructured":"McDonald GB (2010) Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology 51:1450\u20131460. https:\/\/doi.org\/10.1002\/hep.23533","journal-title":"Hepatology"},{"key":"6199_CR9","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3389\/fimmu.2019.02668","volume":"10","author":"NS Nunes","year":"2019","unstructured":"Nunes NS, Kanakry CG (2019) Mechanisms of graft-versus-host Disease Prevention by Post-transplantation Cyclophosphamide: an evolving understanding. Front Immunol 10:2668. https:\/\/doi.org\/10.3389\/fimmu.2019.02668","journal-title":"Front Immunol"},{"key":"6199_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10875-011-9599-2","volume":"32","author":"O Shimony","year":"2012","unstructured":"Shimony O, Nagler A, Gellman YN et al (2012) Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44. J Clin Immunol 32:173\u2013188. https:\/\/doi.org\/10.1007\/s10875-011-9599-2","journal-title":"J Clin Immunol"},{"key":"6199_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/01.tp.0000150210.77543.1b","volume":"79","author":"L Fang","year":"2005","unstructured":"Fang L, Fehse B, Engel M et al (2005) Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells. Transplantation 79:369\u2013371. https:\/\/doi.org\/10.1097\/01.tp.0000150210.77543.1b","journal-title":"Transplantation"},{"key":"6199_CR12","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00277-015-2423-y","volume":"94","author":"J Tischer","year":"2015","unstructured":"Tischer J, Engel N, Fritsch S et al (2015) Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings. Ann Hematol 94:1677\u20131688. https:\/\/doi.org\/10.1007\/s00277-015-2423-y","journal-title":"Ann Hematol"},{"key":"6199_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3324\/haematol.2016.151779","volume":"102","author":"A Ruggeri","year":"2017","unstructured":"Ruggeri A, Sun Y, Labopin M et al (2017) Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant. Haematologica 102:401\u2013410. https:\/\/doi.org\/10.3324\/haematol.2016.151779","journal-title":"Haematologica"},{"key":"6199_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0480-5","author":"N Santoro","year":"2017","unstructured":"Santoro N, Ruggeri A, Labopin M et al (2017) Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-017-0480-5","journal-title":"J Hematol Oncol"},{"key":"6199_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ajh.25087","volume":"93","author":"Z Li","year":"2018","unstructured":"Li Z, Labopin M, Ciceri F et al (2018) Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study. Am J Hematol 93:769\u2013777. https:\/\/doi.org\/10.1002\/ajh.25087","journal-title":"Am J Hematol"},{"key":"6199_CR16","doi-asserted-by":"publisher","unstructured":"Tang F, Xu Y, Chen H et al Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF\/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG). Science China 2020; Life sciences. 63(4): 571\u2013581.https:\/\/doi.org\/10.1007\/s11427-019-9594-7","DOI":"10.1007\/s11427-019-9594-7"},{"key":"6199_CR17","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s11427-019-9585-x","volume":"63","author":"L Xu","year":"2020","unstructured":"Xu L, Fu B, Wang W et al (2020) Haploidentical hematopoietic cell transplantation for severe acquired aplastic anemia: a case-control study of post-transplant cyclophosphamide included regimen vs. anti-thymocyte globulin & colony-stimulating factor-based regimen. Sci China Life Sci 63:940\u2013942. https:\/\/doi.org\/10.1007\/s11427-019-9585-x","journal-title":"Sci China Life Sci"},{"issue":"6","key":"6199_CR18","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3324\/haematol.2020.247296","volume":"106","author":"A Nagler","year":"2021","unstructured":"Nagler A, Kanate AS, Labopin M et al (2021) Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia. Haematologica 106(6):1591\u20131598. https:\/\/doi.org\/10.3324\/haematol.2020.247296","journal-title":"Haematologica"},{"issue":"7","key":"6199_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jtct.2022.04.021","volume":"28","author":"Y Li","year":"2022","unstructured":"Li Y, Lu X, Wang N et al (2022) Comparisons of modified Post-transplantation Cyclophosphamide and Granulocyte Colony-Stimulating Factor\/Antithymocyte Globulin Regimens for haploidentical stem cell transplantation in patients with aplastic Anemia. Transplantation Cell Therapy 28(7):396. https:\/\/doi.org\/10.1016\/j.jtct.2022.04.021","journal-title":"Transplantation Cell Therapy"},{"key":"6199_CR20","doi-asserted-by":"publisher","first-page":"1071268","DOI":"10.3389\/fonc.2023.1071268","volume":"13","author":"L Tang","year":"2023","unstructured":"Tang L, Liu Z, Li T et al (2023) Post-transplant cyclophosphamide versus anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation from unrelated donors: a systematic review and meta-analysis. Front Oncol 13:1071268. https:\/\/doi.org\/10.3389\/fonc.2023.1071268","journal-title":"Front Oncol"},{"key":"6199_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00277-021-04399-x","volume":"100","author":"F Gao","year":"2021","unstructured":"Gao F, Zhang J, Hu J et al (2021) Post-transplant cyclophosphamide versus antithymocyte globulin in allogeneic hematopoietic cell transplantation: a meta-analysis. Ann Hematol 100:529\u2013540. https:\/\/doi.org\/10.1007\/s00277-021-04399-x","journal-title":"Ann Hematol"},{"key":"6199_CR22","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.bbmt.2012.02.013","volume":"18","author":"A Nagler","year":"2012","unstructured":"Nagler A, Labopin M, Shimoni A et al (2012) Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and marrow transplantation. Biol Blood Marrow Transpl 18:1422\u20131429. https:\/\/doi.org\/10.1016\/j.bbmt.2012.02.013","journal-title":"Biol Blood Marrow Transpl"},{"issue":"Suppl 2","key":"6199_CR23","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1038\/bmt.2015.93","volume":"50","author":"A Bacigalupo","year":"2015","unstructured":"Bacigalupo A, Dominietto A, Ghiso A et al (2015) Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update. Bone Marrow Transpl 50(Suppl 2):S37\u201339. https:\/\/doi.org\/10.1038\/bmt.2015.93","journal-title":"Bone Marrow Transpl"},{"key":"6199_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3324\/haematol.2016.144139","volume":"102","author":"SR McCurdy","year":"2017","unstructured":"McCurdy SR, Kasamon YL, Kanakry CG et al (2017) Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide. Haematologica 102:391\u2013400. https:\/\/doi.org\/10.3324\/haematol.2016.144139","journal-title":"Haematologica"},{"key":"6199_CR25","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jcyt.2023.05.012","volume":"25","author":"AG Troullioud Lucas","year":"2023","unstructured":"Troullioud Lucas AG, Lindemans CA, Bhoopalan SV et al (2023) Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis. Cytotherapy 25:977\u2013985. https:\/\/doi.org\/10.1016\/j.jcyt.2023.05.012","journal-title":"Cytotherapy"},{"key":"6199_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-016-0248-3","volume":"9","author":"MT Rubio","year":"2016","unstructured":"Rubio MT, Savani BN, Labopin M et al (2016) Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT. J Hematol Oncol 9:25. https:\/\/doi.org\/10.1186\/s13045-016-0248-3","journal-title":"J Hematol Oncol"},{"key":"6199_CR27","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.bbmt.2016.06.010","volume":"22","author":"R Abboud","year":"2016","unstructured":"Abboud R, Keller J, Slade M et al (2016) Severe cytokine-release syndrome after T cell-replete peripheral blood haploidentical donor transplantation is Associated with poor survival and Anti-IL-6 therapy is safe and well tolerated. Biol Blood Marrow Transpl 22:1851\u20131860. https:\/\/doi.org\/10.1016\/j.bbmt.2016.06.010","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06199-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06199-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06199-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:10:57Z","timestamp":1745575857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06199-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6199"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06199-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"21 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a systematic review and meta-analysis study. Ethics Committee on Biomedical Research, West China Hospital of Sichuan University has confirmed that no ethical approval is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}